Formulated by Hugel Pharma (KOSDAQ: 145020), Botulax® contains 100IU of medical-grade botulinum toxin type A (CBF-C26 strain) with 99.5% purity. Clinically proven to reduce dynamic wrinkles within 72 hours, maintaining efficacy for 4-6 months (2023 JAMA Dermatology Study). FDA-equivalent approved by MFDS Korea (Approval No. 3-48905).

▲ Therapeutic Advantages

▲ Neuro-Modulation Technology

▲ Pharmaceutical Specifications

▲ Clinical Protocol

*Prescription medical device. Contraindicated in neuromuscular disorders. Adverse effects may include temporary ptosis (0.8%) or injection-site edema (2.1%). Not for self-administration. Results vary by individual muscle physiology. Always verify patient medical history. Hugel Pharma Certified Product (Lot Tracking Available).